Di Nardo, Matteo and Ahmad, Ali H. and Merli, Pietro and Zinter, Matthew S. and Lehman, Leslie E. and Rowan, Courtney M. and Steiner, Marie E. and Hingorani, Sangeeta and Angelo, Joseph R. and Abdel-Azim, Hisham and Khazal, Sajad J. and Shoberu, Basirat and McArthur, Jennifer and Bajwa, Rajinder and Ghafoor, Saad and Shah, Samir H. and Sandhu, Hitesh and Moody, Karen and Brown, Brandon D. and Mireles, Maria E. and Steppan, Diana and Olson, Taylor and Raman, Lakshmi and Bridges, Brian and Duncan, Christine N. and Choi, Sung Won and Swinford, Rita and Paden, Matt and Fortenberry, James D. and Peek, Giles and Tissieres, Pierre and De Luca, Daniele and Locatelli, Franco and Corbacioglu, Selim and Kneyber, Martin and Franceschini, Alessio and Nadel, Simon and Kumpf, Matthias and Loreti, Alessandra and Wosten-Van Asperen, Roelie and Gawronski, Orsola and Brierley, Joe and MacLaren, Graeme and Mahadeo, Kris M. (2022) Extracorporeal membrane oxygenation in children receiving haematopoietic cell transplantation and immune effector cell therapy: an international and multidisciplinary consensus statement. LANCET CHILD & ADOLESCENT HEALTH, 6 (2). pp. 116-128. ISSN 2352-4642
Full text not available from this repository. (Request a copy)Abstract
Use of extracorporeal membrane oxygenation (ECMO) in children receiving haematopoietic cell transplantation (HCT) and immune effector cell therapy is controversial and evidence-based guidelines have not been established. Remarkable advancements in HCT and immune effector cell therapies have changed expectations around reversibility of organ dysfunction and survival for affected patients. Herein, members of the Extracorporeal Life Support Organization (ELSO), Pediatric Acute Lung Injury and Sepsis Investigators (PALISI) Network (HCT and cancer immunotherapy subgroup), the Pediatric Diseases Working Party of the European Society for Blood and Marrow Transplantation (EBMT), the supportive care committee of the Pediatric Transplantation and Cellular Therapy Consortium (PTCTC), and the Pediatric Intensive Care Oncology Kids in Europe Research (POKER) group of the European Society of Pediatric and Neonatal Intensive Care (ESPNIC) provide consensus recommendations on the use of ECMO in children receiving HCT and immune effector cell therapy. These are the first international, multidisciplinary consensus-based recommendations on the use of ECMO in this patient population. This Review provides a clinical decision support tool for paediatric haematologists, oncologists, and critical care physicians during the difficult decision-making process of ECMO candidacy and management. These recommendations can represent a base for future research studies focused on ECMO selection criteria and bedside management.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | RENAL REPLACEMENT THERAPY; ORGANIZATION ELSO GUIDELINES; LUNG TRANSPLANTATION; CIRCULATORY SUPPORT; RESPIRATORY-FAILURE; PEDIATRIC ONCOLOGY; INTENSIVE-CARE; OUTCOMES; RECIPIENTS; SURVIVAL |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Abteilung für Pädiatrische Hämatologie, Onkologie und Stammzelltransplantation |
| Depositing User: | Petra Gürster |
| Date Deposited: | 05 Sep 2023 10:15 |
| Last Modified: | 05 Sep 2023 10:15 |
| URI: | https://pred.uni-regensburg.de/id/eprint/58836 |
Actions (login required)
 |
View Item |
